C-RAD Investor Relations Material
Latest events
Q1 2025
C-RAD
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from C-RAD
Access all reports
C-Rad AB, develops, manufactures, and sells systems with applications in radiation therapy for the treatment of cancer. The company offers its products under the C-Rad brand name. The company's endoMulti platform is a digital x-ray equipment with an ionizing radiation emitter and an advanced linac electronics module; and its endoDose platform includes linac platforms that are equipped with C-Rad's advanced dosimetry software. It also provides LINACsystems; and therapeutic linear accelerators and their subsystems. The company markets its products directly to customers through a global network of distributors. The company is based in Uppsala, Sweden.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
CRAD
Country
🇸🇪 Sweden